All Funding Schemes

• Call open

  SFI-HRB-Wellcome Research Partnership

  Access for Irish applicants to funding schemes from Wellcome

• Call open

  HRCI-HRB Joint Funding Scheme 2022 (previously MRCG-HRB)

  HRCI/HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual charity.

• Call open

  ERA PerMed Joint Transnational Call (2022): “Prevention in Personalised Medicine”

  ERAPerMed have launched the fifth Joint Transnational Call for international high-quality research projects to foster research on prevention in Personalised Medicine (PM).

• Call open

  European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (2022): “Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases”

  International collaboration on Rare Disease Research with expected impact to use the results in future for benefit of patients.

• Call open

  Conference and Event Sponsorship Scheme 2022 (CES 2022)

  The Conference and Events Sponsorship Scheme aims to create an opportunity to host health research related events, workshops, or conferences in Ireland.

• HRCI/HRB Joint Funding Scheme 2020 (Previously MRCG-HRB)

  Research projects that address the needs of specific patient populations

• Knowledge Exchange and Dissemination Scheme (KEDS) (Next call TBC)

  Supplementary funding for HRB funded researchers for activities that will maximise the potential impact of the research findings on policy or practice, or communicate research and research findings to the general public.

• European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (To be confirmed))

  This is the second call from European Joint Programme on Rare Diseases (EJP RD). It is a Joint Transnational Call to fund multilateral research projects on rare diseases.

• National Clinical Trials Coordination Programme 2020

  The focus of the call is to support a national clinical trials coordination programme that is aligned to the local supports of the existing clinical trials infrastructures to ensure a harmonised strategic national approach to the conduct of high quality multicentre clinical trials in Ireland.

• HRB Postdoctoral Fellowships - Applying Research into Policy and Practice (ARPP) 2020 (Next call expected 2022)

  Fellowships in applied health research

• Applied Partnership Awards (APA) 2019 (Next call TBC)

  Research projects that address a specific need within the Irish health or social care system

• Definitive Interventions and Feasibility Awards (DIFA) 2020

  Evaluating definitive trials of interventions, and studies in preparation for future definitive interventions

• Fulbright-HRB Health Impact Awards 2021 (next call due in August 2021)

  Research and/or professional development (between three and six months) in the United States of America (USA)

• HRB Postdoctoral Internship Programme 2021

  First-hand experience of working in a State agency alongside experienced professionals

• Summer Student Scholarships (SS) 2022

  Short research projects for undergraduate students in a health or social care-related discipline

• Research visits – Ulysses 2022

  Travel awards for exchange visits to French researchers

• NCI Summer Curriculum in Cancer Prevention (TBC)

  To respond to evolving training needs in the area of cancer prevention, the NCI has confirmed this course will be “under construction” until further notice, with the expectation of updating aspects of the design, content, learning objectives, and delivery modes for diverse audiences. Please check back with CPFP’s website https://cpfp.cancer.gov/summer-curriculum , for updates about future NCI trainings and other existing resources.” Support to attend one or two courses on offer at the National Cancer Institute

• Conference and event sponsorship scheme 2020

  Sponsorship support for seminars/workshops, events and conferences in health research within Ireland.

• Emerging Investigator Awards for Health (EIA) 2022

  Supporting new independent investigators who can facilitate actionable knowledge in health research

• HRB Impact Award 2021 (next call due in 2022)

  The award will recognise a researcher or health professional who has made a significant impact on people’s health or on health policy or practice.

• Joint Transnational Call for Proposals (2019) For 'Personalised Medicine: Multidisciplinary Research Towards Implementation' (Next joint call in Dec 2019)

  ERAPerMed have launched the second Joint Transnational Call for collaborative innovative research projects in PM. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals

• JPND Transnational Call 2019: Multinational research projects on Personalised Medicine for Neurodegenerative Diseases (Next joint call TBC)

  To support ambitious, innovative, multinational and multidisciplinary collaborative research projects to change the trajectory of these debilitating diseases through the development of Precision Medicine approaches.

• Research Leader Awards (RL) 2020 (Next call TBC)

  Supporting established health investigators in academic setting transitioning to leadership in health research.

• Emerging Clinician Scientist Awards (ECSA) 2020 (Next call due in 2022)

  Supporting health and care practitioners currently at mid-stage of their research career transitioning to research independence.

• Research Collaborative in Quality and Patient Safety COVID-19

  Research projects where knowledge users and academic researchers collaborate to focus on Quality and Patient Safety (QPS) research questions of national priority. As a result of the COVID-19 global pandemic, RCQPS is now launching a funding opportunity to support the national research response to the virus outbreak.

• Clinician Scientist Postdoctoral Fellowships (CSF) 2020 (Next call expected 2022)

  Fellowships for Health and Care Practitioners in applied health research.

• Clinical Trial Networks (CTN) 2021

  The overarching aim of the HRB Clinical Trial Network awards is to enable cohesive Networks in specific thematic areas with an agreed research strategy to design, lead and conduct a portfolio of internationally competitive investigator-led, registered clinical trials.

• Joint Transnational Call for Proposals (2020) For “Multidisciplinary Research Projects on Personalized Medicine – Pre-/Clinical Research, Big Data and ICT, Implementation and User’s Perspective”

  ERAPerMed have launched the third Joint Transnational Call for international high-quality research projects in Personalized Medicine (PM). Proposals submitted under this call are expected to demonstrate the applicability of project outcomes to clinical practice.

• JPND Transnational Call 2020: “Novel imaging and brain stimulation methods and technologies related to Neurodegenerative Diseases"

  To support ambitious, innovative, multinational and multidisciplinary collaborative research projects that will further advance the development and the use of imaging technologies and brain stimulation techniques in order to better understand, diagnose or treat neurodegenerative diseases

• ERA-HDHL Call for Joint Transnational Research Proposals: “Development of targeted nutrition for prevention of undernutrition for older adults (PREVNUT)” 2020

  This call intends to fund dedicated, top-class transnational and transdisciplinary research consortia focusing on the prevention of undernutrition in elderly through a proper balance between nutrition, lifestyle and physical exercise or the development of new food products.

• COVID-19 Pandemic Rapid Response Funding Call (COV19 2020)

  Rapid response mechanism to fund research that will provide evidence for the national and global efforts to deal with the virus outbreak.

• National PPI Network

  The HRB and the IRC are now inviting an application for the establishment of a National PPI Network aiming to support and further build capacity for high-quality PPI in research throughout Ireland.

• HRB Clinical Research Facilities/Centres (CRF/C) 2021

  The overarching aim of the HRB Clinical Research Facilities/Centres call is to support/upgrade national CRF/Cs to international standing, increase accessibility to trials for patients and healthy volunteers, and improve the supports available to investigators to drive an increase in investigator-led clinical trials.

• Cancer trials in Ireland 2021

  The overall goal of the new funding model for HRBs investment in cancer trials in Ireland is to support an appropriate infrastructure; enabling Irish patients to access a diverse portfolio of high-quality, safe and compliant cancer clinical trials in Ireland.

• Research Collaborative in Quality and Patient Safety 2021 (RCQPS)

  Research projects where knowledge users and academic researchers collaborate to focus on Quality and Patient Safety (QPS) research questions of national priority.

• Investigator-Led Projects (ILP) 2022

  Projects in (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR).

• DOROTHY Co-Fund Programme: Postdoctoral Fellowships in Public Health Crisis - (Call expected in Q1 2022)

  Postdoctoral fellowships training future experts who can tackle public health crisis.

• Collaborative Doctoral Awards in Patient-focused Research (CDA) 2021 (next call expected in 2023)

  Supporting excellent doctoral training programmes for future health researchers in the conduct of patient-focused research.

• JPI HDHL “Prevention of unhealthy weight gain and obesity during crucial phases throughout the lifespan (PREPHOBES)” 2020

  Proposals will need to focus on one or more crucial phase(s) throughout the lifespan such as transition periods or critical life events.

• ERA-NET NEURON Joint Transnational Call for Proposals (2021) “Multinational and Translational Research Projects on Neurodevelopmental Disorders”

  The aim of the call is to facilitate multinational, collaborative research projects that will address important translational questions relating to the neurodevelopmental nature of neurological and mental disorders.

• ERA-NET JPIAMR-ACTION Call for Joint Transnational Research Proposals (2021) “One Health interventions to prevent or reduce the development and transmission of antimicrobial resistance (AMR)”

  This call advocates for a One Health approach to focus on tackling the rising threat of antibiotic resistance.

• Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL) Call 2021 (STAMIFY)

  Joint Transnational Call "Standardised measurement, monitoring and/or biomarkers to study food intake, physical activity and health (STAMIFY)"

• Secondary Data Analysis Projects (SDAP 2021) - Deadline extended

  Update: The HRB Secondary Data Analysis Projects (SDAP) 2021 call is currently open. The deadline for submission was extended by one week to consider the implications of recent cyberattacks on HSE and related systems. We wish to confirm that the call deadline remains as 13:00 Friday 4th June, and applicants should plan on this basis. We appreciate and regret the fact that a small number of applicant teams may not make this deadline due to the direct and indirect impacts of the cyberattack and we can confirm that there will be further rounds of SDAP that will issue as part of the HRB Strategy (2021-2025). Lead applicants and Host Institutions are being informed of this confirmed deadline. Research projects employing secondary data analysis that supports policy and practice decision making for health and social care.

• ERA-NET TRANSCAN-3 Joint Transnational Call (2021) “Next generation cancer immunotherapy: targeting the tumour microenvironment” UPDATED HRB Guidance and FAQs Documents April 19 2021

  ***** Please note HRB Guidance and FAQ's Documents updated on April 19 2021***** The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new tools and targeted immunotherapy strategies, based on a better understanding of tumour microenvironment (TME) functions and of their impact on the disease course.